These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 10074995)
1. Pregnancy complicated by the antiphospholipid syndrome: outcomes with intravenous immunoglobulin therapy. Clark AL; Branch DW; Silver RM; Harris EN; Pierangeli S; Spinnato JA Obstet Gynecol; 1999 Mar; 93(3):437-41. PubMed ID: 10074995 [TBL] [Abstract][Full Text] [Related]
2. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Branch DW; Peaceman AM; Druzin M; Silver RK; El-Sayed Y; Silver RM; Esplin MS; Spinnato J; Harger J Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):122-7. PubMed ID: 10649166 [TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy. Spinnato JA; Clark AL; Pierangeli SS; Harris EN Am J Obstet Gynecol; 1995 Feb; 172(2 Pt 1):690-4. PubMed ID: 7856708 [TBL] [Abstract][Full Text] [Related]
4. A favorable outcome of pregnancies in women with primary and secondary recurrent pregnancy loss associated with antiphospholipid syndrome. Diejomaoh MF; Al-Azemi MM; Bandar A; Egbase PE; Jirous J; Al-Othman S; Bukhadour N; Al-Sweih N Arch Gynecol Obstet; 2002 Apr; 266(2):61-6. PubMed ID: 12049296 [TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies. Kaaja R; Julkunen H; Ammälä P; Palosuo T; Kurki P Acta Obstet Gynecol Scand; 1993 Jan; 72(1):63-6. PubMed ID: 8382439 [TBL] [Abstract][Full Text] [Related]
7. Use of intravenous immunoglobulin therapy in pregnancy in systemic lupus erythematosus and antiphospholipid antibody syndrome. Gordon C; Kilby MD Lupus; 1998; 7(7):429-33. PubMed ID: 9796843 [TBL] [Abstract][Full Text] [Related]
8. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Backos M; Rai R; Baxter N; Chilcott IT; Cohen H; Regan L Br J Obstet Gynaecol; 1999 Feb; 106(2):102-7. PubMed ID: 10426674 [TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid syndrome and second- or third-trimester fetal death: follow-up in the next pregnancy. Bats AS; Lejeune V; Cynober E; Safar E; Gonzales M; Milliez J; Carbonne B Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):125-9. PubMed ID: 15140503 [TBL] [Abstract][Full Text] [Related]
17. Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study. Ruffatti A; Favaro M; Hoxha A; Zambon A; Marson P; Del Ross T; Calligaro A; Tonello M; Nardelli GB J Reprod Immunol; 2016 Jun; 115():14-9. PubMed ID: 27088752 [TBL] [Abstract][Full Text] [Related]
18. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Rai R; Cohen H; Dave M; Regan L BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487 [TBL] [Abstract][Full Text] [Related]
19. Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome. Venkat-Raman N; Backos M; Teoh TG; Lo WT; Regan L Obstet Gynecol; 2001 Aug; 98(2):235-42. PubMed ID: 11506839 [TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Farquharson RG; Quenby S; Greaves M Obstet Gynecol; 2002 Sep; 100(3):408-13. PubMed ID: 12220757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]